NL-OMON28449已完成不适用
A randomized, prospective, open-label, multi-center study comparing the efficacy and safety of conversion to SIROLIMUS in stable renal or liver transplant recipients with a cutaneous squamous cell carcinoma.
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Wyeth
- 入组人数
- 180
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Organ (kidney or liver) transplant recipient with ³1 biopsy-confirmed cutaneous SCC;
- •2. Age ³18 years and at least 12 months post-transplantation;
排除标准
- •1. Metastatic cutaneous SCC;
- •2. Other malignancies (except for other skin cancers), documented after transplantation;
研究者
相似试验
招募中
不适用
A prospective, open-label, multicenter randomized phase-II trial to evaluate the efficacy and safety of a sequential regimen of obinutuzumab (Gazyvaro) followed by obinutuzumab and venetoclax, followed by either standard venetoclax maintenance or MRD guided venetoclax maintenance in first-line patients with CLL and unfit for FCR-like regimensChronic Lymphocytic Leukemia (CLL)NL-OMON23205HOVON data center70
进行中（未招募）
1 期
A multicentre, randomised, open-label, active-controlled trial of the effectiveness of buprenorphine/naloxone in reducing intravenous buprenorphine misuse in France - RIME StudyFor both compounds, substitution treatment for opioid drug dependence, adult subjects with a diagnosis of major heroin dependence. Only for Suboxone, the intention of naloxone is to deter the intravenous misuse.MedDRA version: 9.1Level: LLTClassification code 10012346Term: Dependence on opiatesEUCTR2009-010360-41-FRReckitt Benckiser Healthcare (UK) Limited270
尚未招募
3 期
Study on effect of calcium supplementation on pregnant womeCTRI/2022/12/047860G.C Chemie Pharmie Limited
进行中（未招募）
不适用
A prospective, randomized, open-label, active-controlled study in adult subjects with acute bacterial sinusitis comparing the clinical efficacy of telithromycin (KETEK®) 800 mg once a day for 5 days versus amoxicillin-clavulanic acid (AUGMENTIN®) 875/125 mg twice a day for 10 days.acute bacterial sinusitis (ABS)MedDRA version: 7.0Level: LLTClassification code 10000858EUCTR2004-001460-42-DEAventis Intercontinental - Sanofi-aventis298
进行中（未招募）
1 期
Effectiveness and safety of MAA868 in patients with irregular heartbeatMedDRA version: 20.0Level: PTClassification code 10003658Term: Atrial fibrillationSystem Organ Class: 10007541 - Cardiac disordersatrial fibrillationEUCTR2017-002741-29-SEovartis Pharma AG600